Sara Nik
Stock Analyst at HC Wainwright & Co.
(2.85)
# 1,613
Out of 5,118 analysts
9
Total ratings
62.5%
Success rate
62.25%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sara Nik
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MBRX Moleculin Biotech | Maintains: Buy | $4 → $22 | $3.44 | +539.53% | 3 | Dec 11, 2025 | |
| KTTA Pasithea Therapeutics | Initiates: Buy | $3 | $1.14 | +163.16% | 1 | Dec 8, 2025 | |
| CDTX Cidara Therapeutics | Downgrades: Neutral | n/a | $220.41 | - | 5 | Nov 14, 2025 |
Moleculin Biotech
Dec 11, 2025
Maintains: Buy
Price Target: $4 → $22
Current: $3.44
Upside: +539.53%
Pasithea Therapeutics
Dec 8, 2025
Initiates: Buy
Price Target: $3
Current: $1.14
Upside: +163.16%
Cidara Therapeutics
Nov 14, 2025
Downgrades: Neutral
Price Target: n/a
Current: $220.41
Upside: -